MDC
Pharmaceuticals, Biotechnology & Life Sciences
Medlab Clinical
- Short interest
- 0.02%
- 0.00 pp 30d
- as of 31 Aug 2021
- Reported shorts
- 59.8K
- Shares on issue
- 342.176M
Medlab Clinical (MDC) company profile
Profile, insiders and operations
Company
AI-generated research profile of Medlab Clinical
Pharmaceuticals
Biotechnology
Research
Development
ASX
Medlab Clinical Limited focuses on the research and development of nutritional pharmaceuticals, aiming to innovate in the biotechnology and life sciences sectors. The company leverages cutting-edge technology to develop products that address unmet medical needs, positioning itself as a leader in the Australian pharmaceutical industry.
Director trades
No director trades found
MDC intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required